FindMyKOL
Clinical trialNCT04027959CompletedInterventional

Transdermal Iontophoresis of Vitamin B12 Under Three Different Skin Preparations

NCT04027959 is an interventional trial sponsored by James J. Peters Veterans Affairs Medical Center. As of 21 Nov 2026, it is completed. It studies Macrocytic Anemia With Vitamin B12 Deficiency. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 5 Oct 2017 and a primary completion date of 4 Oct 2018.

SponsorJames J. Peters Veterans Affairs Medical CenterEnrollment10Macrocytic Anemia With Vitamin B12 Deficiency
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04027959
FieldValue
Registry IDNCT04027959
StatusCompleted
Study typeInterventional trial
Lead sponsorJames J. Peters Veterans Affairs Medical Center
Enrollment10
Registered sites1
Countries1
ConditionsMacrocytic Anemia With Vitamin B12 Deficiency
Start5 Oct 2017
Primary completion4 Oct 2018
Study completion1 Nov 2018
Last update posted14 Dec 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

STUDY DESIGN: Phase I Clinical Trial The researchers set out to assess the effectiveness of transdermal iontophoretic administration of Vitamin B12 (V.B12) under three different skin preparatory conditions. SETTING: James J. Peters Veterans Affairs Medical Center (Bronx, NY) BACKGROUND: Poor skin permeability precludes the use of transdermal route from being used in common clinical practice for rapid and precise administration of medications through intact skin that are expected to have a systemic effect. The researchers determined the relative effectiveness of an unconventional transdermal iontophoresis technique for the administration of Vitamin B12 (V.B12) under three different skin preparatory conditions. METHODS: During this study, Vitamin B12 (V.B12) was administered through the skin of volunteer human research subjects. Iontophoresis was used as transdermal medication delivery modality after pre-treatment of the skin in 3 different ways. The sequence of skin preparations was arranged in a random order for each subject. Method 1 was called "No Prep", serving as the control approach; method 2 was called "Oleic Acid" application to the skin for 40 minutes; and method 3 was hair "Epilation" (e.g. hair removal by plucking). Fifteen milligrams of aqueous solution of V.B12 was administered through intact, previously unused skin of an anterior thigh during all 3 tests. Chemoluminescence, on an automated laboratory reader Advia Centaur-XP, was used to determine the serum concentration of V.B12 prior to and after transdermal iontophoretic delivery. All 3 experiments were performed on the same day within an hour of each other. The subject's blood was drawn prior and 10 minutes after the 20-minute long sessions of transdermal V.B12 iontophoresis. We were able to calculate the increase in serum V.B12 concentration and based on estimated blood volume, the total quantity and percent dose delivered systemically.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • James J Peters Va Medical Center

    The Bronx

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04027959

Each answer restates registry values shown on this page.

What is NCT04027959?

NCT04027959 is an interventional trial sponsored by James J. Peters Veterans Affairs Medical Center. It studies Macrocytic Anemia With Vitamin B12 Deficiency.

Who leads NCT04027959?

The registry names Mark Korsten, MD (principal investigator, Employee) as the overall official.

Where does NCT04027959 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04027959 end?

The registry lists a primary completion date of 4 Oct 2018 and a study completion date of 1 Nov 2018. The sponsor last updated the record on 14 Dec 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.